Clinical trial data from the SURPASS programmea series of phase 3 studies evaluating tirzepatide in type 2 diabetesdocumented injection site reactions including pruritus (itching), erythema (redness), pain, swelling, and bruising
The study didnt look at what happened when patients stop taking the medication though people are known to start regaining weight once they quit the drugs
If youre concerned about affordability, consider these practical steps: Review Your Insurance Plan Carefully Confirm whether your plan covers GLP-1 medications for diabetes, weight loss, or both
Unlike the other GLP-1s, which only target the GLP-1 gut hormone, Zepbound works on a secondary gut hormone called gastric inhibitory polypeptide (GIP)
It is not a medicine, supplement, or approved therapeutic product
A Sustainable Way Forward With Tirzepatide Understanding what to eat with tirzepatide helps patients match their diet with how the medication works in their body